News & Perspective

Dec 05, 2019

Dec 05, 2019

News Scan for Dec 05, 2019

More lettuce E coli
Healthcare MERS cases
Eastern equine encephalitis in Georgia
App for difficult infections
Universal flu vaccine progress

Aug 20, 2019

Aug 20, 2019

News Scan for Aug 20, 2019

More DRC Ebola cases
Flu lingering in Australia
Broadly protective flu patch
Fast-tracked Zika vaccine

Aug 16, 2016

Aug 16, 2016

News Scan for Aug 16, 2016

Malaria may boost Ebola survival
Scallop hepatitis A source
Inhaled vs injectable flu vaccine
Camels and human cold virus
Venezuela malaria spike

Mar 10, 2015

Mar 10, 2015

Flu Scan for Mar 10, 2015

More queries on flu vaccine mismatch
Global flu activity

Dec 11, 2009

Dec 11, 2009

New vaccine technologies on horizon but face roadblocks

(CIDRAP News) – New ways of producing influenza vaccine that would free the process from long-standing problems are on the horizon, federal officials said today, but they added that scientific and regulatory hurdles will slow the products' movement past licensure and into the market.

Nov 24, 2009

Nov 24, 2009

Novartis unveils US cell-based flu vaccine plant

(CIDRAP News) – The era of cell-based influenza vaccine production in the United States seemed to move closer today as Novartis unveiled its new, nearly billion-dollar manufacturing plant in Holly Springs, N.C., but onshore production and marketing of cell-based vaccines remains a few years away.

Sep 11, 2009

Sep 11, 2009

More results point to 1-dose regimen for H1N1 vaccines

(CIDRAP News) – US health officials offered more evidence today that a single dose of pandemic H1N1 influenza vaccines may be enough to protect adults, saying preliminary findings in government-sponsored trials reinforce early results from company trials announced yesterday.

Aug 21, 2009

Aug 21, 2009

First H1N1 vaccine trial data expected in mid-September

(CIDRAP News) – Federal health officials today said the first results of novel H1N1 vaccine trials—needed for determining the number and size of doses people will get—are expected in mid-September.

Two trials in adult and elderly volunteers started Aug 7 and are now almost fully enrolled, said Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), at a press teleconference.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»